Open AccessSGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases which are the benefits
Author(s) -
Camelia Diaconu,
Teodor Salmen,
Mihnea A Gaman,
Ovidiu Gabriel Bratu,
Dan Mischianu,
Radu D Marcu,
Andra I Suceveanu,
Raluca Costache,
Anca Pantea Stoian
Publication year - 2019
Publication title -
romanian journal of military medicine
Language(s) - English
Resource type - Journals
eISSN - 2501-2312
pISSN - 1222-5126
DOI - 10.55453/rjmm.2019.122.1.2
Subject(s) - empagliflozin , heart failure , medicine , ejection fraction , canagliflozin , diabetes mellitus , type 2 diabetes , cardiology , intensive care medicine , endocrinology